Top compounds associated with response to CTSO


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC -0.096 0.002
mRNA TGX221 GDSC1000 pan-cancer AAC 0.15 0.002
mRNA MI-1 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA AZD6482 GDSC1000 pan-cancer AAC 0.099 0.003
mRNA GSK525762A CTRPv2 pan-cancer AAC 0.091 0.003
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.1 0.003
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.091 0.003
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Midostaurin GDSC1000 pan-cancer AAC 0.1 0.003
Download CSV